GENNIEFY
Market News
Latest financial news and analysis from global markets
GOOGL
Why embracing AI may be the key to career survival
Glassdoor Senior Economist Daniel Zhao joins Brooke DiPalma on Market Domination to discuss employee confidence as companies continue trimming headcount and accelerating AI-driven workplace changes. Zhao explains why workers who embrace AI tools and adapt their skill sets may be better positioned for long-term job security.
AAPL
Vanguard Total Stock Market Index Fund ETF Shares (VTI): Graham Stephan Remains Bullish
We just covered the Graham Stephan Stock Portfolio: Top 11 Stocks and Vanguard Total Stock Market Index Fund ETF Shares (NYSE:VTI) ranks 8th on this list. Graham Stephan is a big proponent of investing in funds like Vanguard Total Stock Market Index Fund ETF Shares (NYSE:VTI). He believes they lower the risk profile of the […]
GOOGL
Vanguard Total Stock Market Index Fund ETF Shares (VTI): Graham Stephan Remains Bullish
We just covered the Graham Stephan Stock Portfolio: Top 11 Stocks and Vanguard Total Stock Market Index Fund ETF Shares (NYSE:VTI) ranks 8th on this list. Graham Stephan is a big proponent of investing in funds like Vanguard Total Stock Market Index Fund ETF Shares (NYSE:VTI). He believes they lower the risk profile of the […]
MSFT
Vanguard Total Stock Market Index Fund ETF Shares (VTI): Graham Stephan Remains Bullish
We just covered the Graham Stephan Stock Portfolio: Top 11 Stocks and Vanguard Total Stock Market Index Fund ETF Shares (NYSE:VTI) ranks 8th on this list. Graham Stephan is a big proponent of investing in funds like Vanguard Total Stock Market Index Fund ETF Shares (NYSE:VTI). He believes they lower the risk profile of the […]
MSFT
Sector Update: Tech Stocks Gain Late Afternoon
Tech stocks were higher late Wednesday afternoon, with the State Street Technology Select Sector SPD
TSLA
Vanguard S&P 500 ETF (VOO): Graham Stephan Likes This Index Fund
We just covered the Graham Stephan Stock Portfolio: Top 11 Stocks and Vanguard S&P 500 ETF (NYSE:VOO) ranks 7th on this list. Vanguard S&P 500 ETF (NYSE:VOO) is another index fund that Graham Stephan has recommended his followers buy on multiple occasions. The Vanguard S&P 500 ETF employs an indexing investment approach designed to track […]
AVGO
Vanguard S&P 500 ETF (VOO): Graham Stephan Likes This Index Fund
We just covered the Graham Stephan Stock Portfolio: Top 11 Stocks and Vanguard S&P 500 ETF (NYSE:VOO) ranks 7th on this list. Vanguard S&P 500 ETF (NYSE:VOO) is another index fund that Graham Stephan has recommended his followers buy on multiple occasions. The Vanguard S&P 500 ETF employs an indexing investment approach designed to track […]
MSFT
Vanguard 500 Index Fund (VFIAX): Top Stock Pick by Graham Stephan
We just covered the Graham Stephan Stock Portfolio: Top 11 Stocks and Vanguard 500 Index Fund (NASDAQ:VFIAX) ranks 6th on this list. Vanguard 500 Index Fund (NASDAQ:VFIAX) is an index fund that Graham Stephan has advocated buying in the past few years. The Vanguard 500 Index Fund employs an indexing investment approach designed to track […]
AAPL
Vanguard 500 Index Fund (VFIAX): Top Stock Pick by Graham Stephan
We just covered the Graham Stephan Stock Portfolio: Top 11 Stocks and Vanguard 500 Index Fund (NASDAQ:VFIAX) ranks 6th on this list. Vanguard 500 Index Fund (NASDAQ:VFIAX) is an index fund that Graham Stephan has advocated buying in the past few years. The Vanguard 500 Index Fund employs an indexing investment approach designed to track […]
GOOGL
Vanguard 500 Index Fund (VFIAX): Top Stock Pick by Graham Stephan
We just covered the Graham Stephan Stock Portfolio: Top 11 Stocks and Vanguard 500 Index Fund (NASDAQ:VFIAX) ranks 6th on this list. Vanguard 500 Index Fund (NASDAQ:VFIAX) is an index fund that Graham Stephan has advocated buying in the past few years. The Vanguard 500 Index Fund employs an indexing investment approach designed to track […]
WMT
Claire's expands footprint into these major retailers. See where
Claire's filed for Chapter 11 bankruptcy in August 2025, the chain's second bankruptcy filling in seven years.
NEE
Monashee Scales Back Its Bet on Structure Therapeutics
This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity.